Wedbush Starts Harpoon Therapeutics (HARP) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Canaccord Genuity Starts Harpoon Therapeutics (HARP) at Buy
March 5, 2019 6:16 AM ESTCanaccord Genuity analyst Arlinda Lee initiates coverage on Harpoon Therapeutics (NASDAQ: HARP) with a Buy rating and a price target of $24.00.
For an analyst ratings summary and ratings history on Harpoon Therapeutics click here. For more ratings news on Harpoon Therapeutics click here.
Shares of Harpoon Therapeutics closed at $17.01 yesterday.
... More